Understanding the CARES Act

An informative summary that offers a synopsis of key changes initiated by the Act.

YES! I want to know more about the CARES Act and receive the “Understanding the CARES Act: An overview of key highlights in the bill.”

First Name:*

Last Name:*

Email:*

Phone:*

Firm:

State:*

* Required Fields

Today’s markets are dynamic and you need to be able to respond to them. Guggenheim understands your need for flexibility with a line-up of 57 Rydex Funds that offer exposure to today’s most popular benchmarks. Unlike many other funds, which may have holding period restrictions, the Rydex funds offer unlimited exchange privileges—no holding periods and no transaction fees—among equivalent share classes of the Rydex funds. Keep in mind that certain share classes may impose sales charges on new purchases or for early redemption and other account fees such as fund expenses, brokerage commissions and service fees may apply.

The $2 trillion coronavirus-relief bill, often referred to as the “CARES Act,” contains important provisions that will affect investors’ financial plans. This Overview offers a synopsis of key changes initiated by the Act.

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.

Investing involves risk, including the possible loss of principal.

Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.

This is not an offer to sell nor a solicitation of an offer to buy the securities herein. Only a Guggenheim Credit Income Fund 2019 (GCIF 2019) prospectus makes such an offer. This material is authorized only when it is accompanied or preceded by a GCIF 2019 prospectus. Neither the SEC nor the Attorney General of the State of New York nor any other state regulator has passed on or endorsed the merits of this offering. Any representation to the contrary is a criminal offense. Securities are offered through Guggenheim Funds Distributors, LLC, member of FINRA/SIPC, as Dealer Manager.

Research our firm with FINRA Broker Check.

• Not FDIC Insured • No Bank Guarantee • May Lose Value

This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.